Raptim Research Private Limited (formerly known as Raptim Research Limited), founded in 2005 has been one of the fastest-growing CRO (Contract Research Organization). Raptim is a full-service CRO in early and late phase studies providing multiple research services for pharmaceutical, biotechnology, and generic drug industries. Raptim stands for “Rapid Time” as our primary goal is to provide fast turnaround quality study results to help in the sponsor’s approval process of regulatory submission and product approvals.
Raptim has operational facilities in Mumbai (Maharashtra) and Gandhinagar (Gujarat) in India, and a marketing office in New Jersey, USA.
Raptim Research is a full-service provider focused on early and late phase clinical research services with 15 years of experience. Our support services include large and small molecule Bio-analysis, Clinical Pharmacology, In-vitro Studies, Feeding Tube Studies, BCS Biowaiver studies, Data Management, Biostatistics, Regulatory Support, and Project Management.
To achieve the fastest path to regulatory, scientific and clinical approvals of drugs, biologics, and medical devices while maintaining the highest ethical and scientific standards.
Our goal is to become the leader in Clinical Research, to achieve wider reach to customers with unmatched service quality, to remain committed to our Human Care Management and to continue to garner more international regulatory approvals as we strive for a greater global presence.